Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Immucor has received and confirmed reports of this reagent lot demonstrating weak reactivity with rare examples of le(a+b-) red blood cells. due to the unexpected reactivity this lot has demonstrated immucor has decided to withdraw this lot from the market. this issue was first reported/discovered on 2011-06-01.